ANAVEX LIFE SCIENCES CORP. Annual Report - How They Did This Year (Fiscal Year Ended September 30, 2025)

This report covers ANAVEX LIFE SCIENCES CORP.'s performance for the fiscal year that ended on September 30, 2025.

Anavex is considered a "well-known seasoned issuer" and a "large accelerated filer" by the SEC. They have confirmed that they've filed all their required reports and have strong internal controls over their finances.

As of March 31, 2025, the company's market value for shares held by regular investors (not insiders) was around $708 million, based on a share price of $8.58. By November 24, 2025, there were approximately 89.3 million shares of common stock outstanding.

The company is heavily involved in research and development (R&D). Their R&D costs are broken down into areas like preclinical studies, clinical trials, personnel costs, and non-cash share-based compensation. They also have some international activities, as indicated by mentions of Australian currency.

The company has a purchase agreement with Lincoln Park Capital Fund LLC from 2023, which allows them to raise money by potentially issuing common stock to fund their ongoing research and operations.

Key Takeaways for Investors:

• Established Reporting: Anavex is recognized by the SEC as a "well-known seasoned issuer" and "large accelerated filer," indicating a history of timely and comprehensive financial reporting and strong internal controls.
• Market Snapshot: As of March 31, 2025, the market value of shares held by regular investors was approximately $708 million. The company had about 89.3 million shares of common stock outstanding by November 24, 2025.
• R&D Focused: The company's operations are heavily centered on research and development, with costs allocated to preclinical studies, clinical trials, personnel, and share-based compensation.
• Funding Strategy: Anavex has a purchase agreement with Lincoln Park Capital Fund LLC to potentially issue common stock, providing a mechanism to fund ongoing research and operations.
• International Presence: The company's activities include an international component, evidenced by mentions of Australian currency.